FEATURED EDITORIAL
The 2026 Inaugural Non-Opioid Pain Therapeutics Summit brought together a diverse group of scientists, clinicians, and drug hunters to discuss developing safe, effective pain medicines without the addictive properties associated with opioids.
- Targeting Underlying Biology: Novel Combination Therapies For Chronic Disease
- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
- Charting The Future Of Antimicrobial Resistance
- Annual Reflections And Predictions From The Editors' Roundtable
- The FXI Gamble: To Bleed Less... Or To Protect Less?
- Hibernating Squirrels May Hold Clues To Treating Heart Failure
- Engineering Therapeutics With A Structural Approach
FEATURED APPLICATION CONTENT
-
Explore how advanced single‑cell analysis links CAR localization, cell structure, and functional behavior, offering deeper insight into CAR T cell heterogeneity and performance.
-
Gain insight into automating DNA size selection that shows how optimized bead ratios and programmable handling improve fragment recovery, consistency, and throughput.
-
Gain insight into an automated high‑input workflow that streamlines long‑read whole‑genome library prep, supporting large DNA fragments while reducing reagent use.
-
A streamlined workflow reduces reagent use and hands‑on time while preserving long‑read sequencing quality. See how multiplexed offer an efficient option for scaling or mobilizing sequencing efforts.
-
Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.
-
Discover how mixed-mode chromatography enables high-yield purification of single-domain antibodies under mild conditions and why these approaches outperform traditional resins.
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
-
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.
-
Discover how a CDMO achieved 40x productivity and 15% cost savings by switching to rapid cycling membrane chromatography for ADC polishing, which helped cut process time and buffer use.
- Insights From The Non-Opioid Pain Therapeutics Summit: Human-Centric Translational Models And The Reawakening Of Pain Pipelines
- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
- Annual Reflections And Predictions From The Editors' Roundtable
- The Unlikely Weapon Against Fentanyl: Your Immune System
- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
FEATURED NEWS HEADLINES
- VoxCell Appoints Chief Commercial Officer As Demand Grows For Predictive, Human-Relevant, Non-Clinical Testing Approaches
- SGD Pharma Leads Pharma Packaging Innovation And Decarbonization At PharmaPack Europe 2026
- Insilico Medicine And Qilu Pharmaceutical Reach Near $120M Drug Development Collaboration To Accelerate Novel Cardiometabolic Therapies
- Drug Farm Announces FDA Fast Track Designation For First-In-Class ALPK1 Inhibitor DF-003 For The Treatment Of ROSAH Syndrome
- Mair Therapeutics Announces Scientific Collaboration With Radboud University To Advance TMEM175 Agonists For Parkinson's Disease
- Lunai Bioworks Expands NIH-Funded AI Program Into Commercial Alcohol Use Disorder Drug Discovery
- Novaliq Receives FDA IND Clearance To Advance NOV05 In A Phase II Clinical Trial In Non-Infectious Anterior Uveitis
- New Platform To Accelerate Cardiac Drug Development
- Ellipses In-Licenses First-In-Class B7H3 Antibody Drug Conjugate From China
- Voyager Enables Microgravity-Enabled Drug Discovery
ARCHIVED NEWSLETTER
- 02.03.26 -- CROs In Early Drug Discovery, Part 3: Budgets, Timelines, And Avoiding Pitfalls
- 01.27.26 -- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
- 01.20.26 -- CROs In Early Drug Discovery, Part 1: Choosing The Right Partner
- 01.13.26 -- Reflections And Predictions From The Editors' Roundtable
- 01.06.26 -- The Unlikely Weapon Against Fentanyl: Your Immune System